Sign In
Buy TBPH
Theravance Biopharma Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -73.01. In total, the insiders bought 588.31K and sold 861.64K TBPH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-73.01 |
| ● Buy | 588.31K shares |
| ● Sell | 861.64K shares |
|
35% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 15, 2026 Sell |
Farnum Rhonda SVP, Comm & Medical Affairs |
3 328 Value: $54.5K |
||
|
Jun 15, 2026 Sell |
Farnum Rhonda SVP, Comm & Medical Affairs |
3 329 Value: $54.6K |
||
|
Jun 15, 2026 Sell |
Farnum Rhonda SVP, Comm & Medical Affairs |
6 657 Value: $109.1K |
||
|
Jun 12, 2026 Buy |
Pakianathan Deepika Director |
13 398 Value: $222.9K |
||
|
Jun 12, 2026 Buy |
O'connor Donal Director |
13 398 Value: $222.9K |
||
|
Jun 12, 2026 Buy |
Mitchell Dean J Director |
6 009 Value: $100.0K |
||
|
Jun 12, 2026 Buy |
Gray Susannah Director |
13 398 Value: $222.9K |
||
|
Jun 12, 2026 Buy |
Gray Susannah Director |
6 009 Value: $100.0K |
||
|
Jun 12, 2026 Buy |
Smaldone Alsup Laurie Director |
13 398 Value: $222.9K |
||
|
Jun 12, 2026 Buy |
Smaldone Alsup Laurie Director |
6 009 Value: $100.0K |
||
|
Jun 12, 2026 Buy |
Mitchell Dean J Director |
13 398 Value: $222.9K |
||
|
Jun 12, 2026 Buy |
O'connor Donal Director |
6 009 Value: $100.0K |
||
|
Jun 12, 2026 Buy |
Pakianathan Deepika Director |
6 009 Value: $100.0K |
||
|
May 20, 2026 Sell |
Grimaud Brett A. SVP, Gen Counsel And Secretary |
8 829 Value: $146.1K |
||
|
May 20, 2026 Sell |
Winningham Rick E Chief Executive Officer |
20 038 Value: $331.6K |
||
|
May 20, 2026 Sell |
Sawaf Aziz SVP & Chief Financial Officer |
8 670 Value: $143.5K |
||
|
May 20, 2026 Sell |
Miller Aine SVP, Dev & Head Of Ire Office |
6 827 Value: $113.0K |
||
|
May 20, 2026 Sell |
Farnum Rhonda SVP, Comm & Medical Affairs |
5 678 Value: $94.0K |
||
|
Apr 01, 2026 Buy |
Sawaf Aziz SVP & Chief Financial Officer |
37 500 Value: $594.0K |
||
|
Apr 01, 2026 Buy |
Winningham Rick E Chief Executive Officer |
75 000 Value: $1.19M |
||
|
Apr 01, 2026 Buy |
Grimaud Brett A. SVP, Gen Counsel And Secretary |
37 500 Value: $594.0K |
||
|
Apr 01, 2026 Buy |
Farnum Rhonda SVP, Comm & Medical Affairs |
18 750 Value: $297.0K |
||
|
Mar 16, 2026 Sell |
Farnum Rhonda SVP, Comm & Medical Affairs |
7 766 Value: $108.1K |
||
|
Mar 16, 2026 Sell |
Farnum Rhonda SVP, Comm & Medical Affairs |
15 534 Value: $217.5K |
||
|
Mar 16, 2026 Sell |
Farnum Rhonda SVP, Comm & Medical Affairs |
7 767 Value: $108.1K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
